CN108142936A - A kind of marine organism type special medicine purposes formula food for tumor patient - Google Patents
A kind of marine organism type special medicine purposes formula food for tumor patient Download PDFInfo
- Publication number
- CN108142936A CN108142936A CN201810073989.7A CN201810073989A CN108142936A CN 108142936 A CN108142936 A CN 108142936A CN 201810073989 A CN201810073989 A CN 201810073989A CN 108142936 A CN108142936 A CN 108142936A
- Authority
- CN
- China
- Prior art keywords
- formula food
- protein
- clam worm
- acid
- vitamin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
- A23L17/70—Comminuted, e.g. emulsified, fish products; Processed products therefrom such as pastes, reformed or compressed products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pediatric Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
本发明属于特殊医学用途配方食品领域,涉及一种适用于肿瘤患者的海洋生物型特殊医学用途配方食品及其制备方法,特别将沙蚕作为肠内营养制剂的蛋白质来源。使用方式可经胃肠内管道直接给予,也可以口服。本发明提供的用于肿瘤患者的海洋生物型特殊医学用途配方食品,按重量百分比,由以下营养成分组成:蛋白质20~30%,脂肪5~10%,碳水化合物70~75%,胆碱0.090~0.100%,肌醇15~20%,牛磺酸0.035~0.06%,余量为质量比为1:20~30的复合维生素和矿物质元素;所述20‑60%蛋白质的来源于沙蚕粉。本发明提供的沙蚕特殊医学用途配方食品组与谷氨酰胺+精氨酸蛋白质来源特殊医学用途配方食品组相比有更好的营养支持效果,且双齿围沙蚕蛋白占制剂总蛋白60%时,营养功效最显著。
The invention belongs to the field of formula food for special medical use, and relates to a marine biological formula food for special medical purpose suitable for tumor patients and a preparation method thereof. In particular, lugworm is used as a protein source of enteral nutrition preparations. The mode of use can be directly administered through the gastrointestinal tract, and can also be taken orally. The marine organism type special medical formula food for tumor patients provided by the present invention is composed of the following nutritional components in percentage by weight: 20-30% protein, 5-10% fat, 70-75% carbohydrate, and 0.090 choline ~0.100%, inositol 15~20%, taurine 0.035~0.06%, and the balance is multivitamins and mineral elements with a mass ratio of 1:20~30; the 20‑60% protein comes from clam worms pink. Compared with the glutamine + arginine protein-sourced formula food group for special medical purposes, the clam worm formula food group provided by the present invention has a better nutritional support effect, and the clam worm protein accounts for 60% of the total protein of the preparation %, the nutritional efficacy is most significant.
Description
技术领域technical field
本发明属于特殊医学用途配方食品领域,涉及一种适用于肿瘤患者的海洋生物型特殊医学用途配方食品及其制备方法,特别将沙蚕作为肠内营养制剂的蛋白质来源。使用方式可经胃肠内管道直接给予,也可以口服。The invention belongs to the field of formula food for special medical use, and relates to a marine biological formula food for special medical purpose suitable for tumor patients and a preparation method thereof. In particular, lugworm is used as a protein source of enteral nutrition preparations. The mode of use can be directly administered through the gastrointestinal tract, and can also be taken orally.
背景技术Background technique
恶性肿瘤是临床常见疾病,也是当前及今后相当长一段时间内威胁人类健康和导致死亡的主要原因。肿瘤病人因肿瘤异常生长和代谢、疼痛、梗阻而存在不同程度的营养不良。基于免疫与营养密切相关,因此采用合理的营养支持改善肿瘤患者机体的免疫功能,成为食品研究的前沿方向。同时,应用肠内营养支持辅助治疗癌症及危重病患者也受到越来越多的重视。Malignant tumor is a common clinical disease, and it is also the main cause of threatening human health and causing death at present and for a long time to come. Cancer patients suffer from various degrees of malnutrition due to abnormal tumor growth and metabolism, pain, and obstruction. Based on the close relationship between immunity and nutrition, using reasonable nutritional support to improve the immune function of tumor patients has become the frontier direction of food research. At the same time, more and more attention has been paid to the application of enteral nutrition support in the adjuvant treatment of cancer and critically ill patients.
研究表明,肠内营养(Enteral nutrition,EN)可以改善肠道功能,减少内毒素入血和体内炎症介质的释放。肿瘤型肠内营养制剂主要应用在重症患者手术前后以及放疗和化疗期间。目前我国肠内营养制剂主要来自于欧洲进口,国内上市的EN制剂产品所采用的原材料主要为陆源性动植物及其提取物,其中蛋白质源主要为大豆蛋白、牛奶蛋白和鸡蛋蛋白或水解植物蛋白及其衍生物。用新型蛋白源开发安全有效的肠内营养制剂,也是临床EN制剂领域或特殊医学用途配方食品领域的重要研究内容。Studies have shown that enteral nutrition (Enteral nutrition, EN) can improve intestinal function, reduce endotoxin into the blood and release of inflammatory mediators in the body. Tumor-type enteral nutrition preparations are mainly used in critically ill patients before and after surgery and during radiotherapy and chemotherapy. At present, my country's enteral nutrition preparations are mainly imported from Europe. The raw materials used in the domestic marketed EN preparations are mainly terrestrial animals and plants and their extracts, and the protein sources are mainly soybean protein, milk protein, egg protein or hydrolyzed vegetable protein. and its derivatives. The development of safe and effective enteral nutrition preparations with new protein sources is also an important research content in the field of clinical EN preparations or formula foods for special medical purposes.
沙蚕属于药食同源的海洋生物,也是鱼虾的天然饲料。双齿围沙蚕具有补脾益胃、补血养血、利水消肿等功效。其营养成分丰富,氨基酸含量占干重的67.43%,脂肪酸含量占干重的14.24%,其中EPA含量为6.53%,还含有Cu、Sn、Se、Hg、As、I、Zn和Cd等多种微量元素。沙蚕中含有的超氧化物歧化酶、纤维蛋白溶解酶、纤维酶原激活物、胶原酶等活性成分具有优良的抗衰老、抗肿瘤、抗炎症和预防高血压、消除动脉硬化等功效。沙蚕蛋白中高比例的精氨酸和谷氨酰胺可通过维持免疫细胞的功能性完整来支持重症患者免疫系统的内环境稳态。沙蚕中含有的ω-3脂肪酸,能够有效延迟炎症反应,预防自由基损伤。我们在研究中发现,沙蚕的人体必需氨基酸含量占总氨基酸的比例高达47.21%,必需氨基酸与非必需氨基酸的比值为89%,根据FAO/WH0(1973)提出的的理想蛋白质中人体必需氨基酸含量的模式,质量较佳的蛋白质其氨基酸组成为必需氨基酸/总氨基酸在40%左右,必需氨基酸/非必需氨基酸在60%以上,我们选用的沙蚕氨基酸组成即满足这一标准,因此可以说双齿围沙蚕是一种具有广阔开发前景的优质原料。Nereist worm is a marine organism with the same source of medicine and food, and it is also a natural feed for fish and shrimp. The double-toothed clamworm has the effects of nourishing the spleen and stomach, nourishing blood and nourishing blood, promoting water and reducing swelling. It is rich in nutrients, the amino acid content accounts for 67.43% of the dry weight, the fatty acid content accounts for 14.24% of the dry weight, of which the EPA content is 6.53%, and it also contains Cu, Sn, Se, Hg, As, I, Zn and Cd, etc. trace elements. Active ingredients such as superoxide dismutase, fibrinolytic enzyme, plasminogen activator, and collagenase contained in clamworm have excellent anti-aging, anti-tumor, anti-inflammation, prevention of high blood pressure, and elimination of arteriosclerosis. The high proportion of arginine and glutamine in nereis protein can support the homeostasis of the immune system in critically ill patients by maintaining the functional integrity of immune cells. The omega-3 fatty acids contained in clamworm can effectively delay the inflammatory response and prevent free radical damage. We found in the research that the essential amino acid content of clamworms accounts for 47.21% of the total amino acids, and the ratio of essential amino acids to non-essential amino acids is 89%. The mode of content, the amino acid composition of protein with better quality is about 40% of essential amino acids/total amino acids, and more than 60% of essential amino acids/non-essential amino acids. The double-toothed clamworm is a high-quality raw material with broad development prospects.
近年来,营养支持在肿瘤临床工作中的不可或缺性越来越得到专业人士的认可。目前市场上的肠内营养制剂产品均为单纯的全营养素,添加的一种或几种“药食同源”食材,仅作为营养功能组件,其作用局限在营养支持而不能达到特异性针对放、化疗所产生的免疫力降低、胃肠道功能紊乱、骨髓抑制、恶心、呕吐、脱发、粘膜损伤等一系列副作用,且由于市场上的产品大多由欧美制造,其营养素的摄入量和配比也并非完全适合我国居民。因此,研制使用于肿瘤患者的特殊医学用途配方食品具有重要意义。In recent years, the indispensability of nutritional support in clinical tumor work has been increasingly recognized by professionals. Currently, the enteral nutrition preparations on the market are purely complete nutrients, and one or several "medicine and food homologous" ingredients added are only used as nutritional functional components. , a series of side effects such as reduced immunity, gastrointestinal dysfunction, bone marrow suppression, nausea, vomiting, hair loss, and mucosal damage caused by chemotherapy. The ratio is not entirely suitable for our residents. Therefore, it is of great significance to develop formula foods for special medical purposes used in cancer patients.
发明内容Contents of the invention
针对现有肿瘤患者特殊医学用途配方食品的不足,本发明的目的之一是基于肿瘤患者代谢异常的病理特点和制剂配制要求与质量指标,设计提供一种能改善肿瘤患者的生活质量,补充肿瘤患者的营养,延长肿瘤患者生存时间的肝癌前病变患者用的海洋生物型特殊医学用途营养配方食品。In view of the deficiency of the existing formula food for special medical use of tumor patients, one of the purposes of the present invention is to design and provide a kind of food that can improve the quality of life of tumor patients and supplement tumor The nutrition of patients, marine biological special medical nutritional formula food for patients with liver precancerous lesions that prolongs the survival time of tumor patients.
1、沙蚕营养物质的测定1. Determination of Nutrients in Nereis worm
配置符合肝癌前病变患者的特殊医学用途配方食品,需通过实验测定沙蚕中各种物质的含量,检测方法及实验结果如下表1和表2。To configure formula food for special medical purposes that meets the requirements of patients with precancerous liver lesions, the content of various substances in clam worms needs to be determined through experiments. The detection methods and experimental results are shown in Tables 1 and 2 below.
表1双齿围沙蚕营养成分检测方法及标准Table 1 Detection methods and standards of nutritional components of P. didentensis
表2双齿围沙蚕的营养成分分析Table 2 Analysis of nutritional components of P.
2、沙蚕特殊医学用途配方食品中物质配比依据2. Proportion basis of substances in clam worm formula food for special medical purpose
本发明专利配方严格依据GB29922-2013《特殊医学用途配方食品通则》中适用于10岁以上人群的全营养配方食品要求以及附录中关于肿瘤患者的全营养配方食品的特殊说明及相关文献资料计算。具体见表3、表4和表5。The patented formula of the present invention is calculated strictly according to the requirements of full-nutrition formula food applicable to people over 10 years old in GB29922-2013 "General Rules for Formula Foods for Special Medical Purposes", as well as the special instructions on full-nutrition formula food for tumor patients in the appendix and relevant literature. See Table 3, Table 4 and Table 5 for details.
表3维生素和矿物质指标(10岁以上人群)Table 3 Vitamin and mineral indicators (people over 10 years old)
表4可选择性成分指标(10岁以上群)Table 4 Optional component indicators (group over 10 years old)
表5肿瘤患者的全营养配方食品Table 5 Complete nutritional formula food for cancer patients
3、沙蚕特殊医学用途配方食品中主要物质添加量确定原则:热量≧295KJ(70kcal)/100g3. Principles for determining the amount of main substances added to clam worm formula food for special medical purposes: calories ≧ 295KJ (70kcal)/100g
蛋白质≧0.8g/100KJ(3.5g/100kcal)Protein≧0.8g/100KJ (3.5g/100kcal)
亚油酸供能比≧2.0%Energy supply ratio of linoleic acid≧2.0%
肿瘤病人特殊功能比:蛋白质:15-20%;碳水化合物:60-65%;脂肪:15-20%。Special function ratio of tumor patients: protein: 15-20%; carbohydrate: 60-65%; fat: 15-20%.
公式:formula:
(总能量)KJ/100g=((碳水化合物)g×17KJ/g+(蛋白质)g×17KJ/g+(脂肪)g×37KJ/g/100g=1816.85KJ(Total energy) KJ/100g=((carbohydrate) g×17KJ/g+(protein)g×17KJ/g+(fat)g×37KJ/g/100g=1816.85KJ
(蛋白质)g=(1816.85KJ×20%)/17KJ/g(Protein) g=(1816.85KJ×20%)/17KJ/g
(脂肪)g=(1816.85KJ×14.54%)/37KJ/g(Fat) g=(1816.85KJ×14.54%)/37KJ/g
(碳水化合物)g=(1816.85KJ×65.45%)/17KJ/g(carbohydrate) g=(1816.85KJ×65.45%)/17KJ/g
依据以上配方原则和公式计算配方中各物质含量。Calculate the content of each substance in the formula according to the above formula principles and formulas.
4、沙蚕特殊医学用途配方食品碳水化合物的确定4. Determination of carbohydrates in clam worm formula food for special medical purposes
压片过程中开始确定的碳水化合物的添加吴志伟玉米淀粉、麦芽糊精、葡萄糖、蔗糖和微晶纤维素,但经过压片实验发现很过问题,如片剂太软不成形,片剂容易受潮,或片剂太硬等问题,但经过多次调整碳水化合物的添加物质和量的确定,并调整又经过压片实验,最终确定了配方中的碳水化合物的添加物质为:麦芽糊精、乳糖、低取代羟丙基纤维素和微晶纤维素。其中麦芽糊精和乳糖在配方中起到粘合剂的作用,低取代羟丙基纤维素和微晶纤维素起到解崩剂的作用,并添加了适当量的硬脂酸镁作为配方中的润滑剂,最终压除了成型的沙蚕特殊医学用途配方食品片剂。Carbohydrates were initially determined during the tableting process. Wu Zhiwei corn starch, maltodextrin, glucose, sucrose and microcrystalline cellulose were added, but after tableting experiments, many problems were found, such as the tablet was too soft to form, and the tablet was easily affected by moisture. , or the tablet is too hard, etc., but after several adjustments to determine the added substances and amounts of carbohydrates, and after adjustments and tablet compression experiments, it was finally determined that the added substances of carbohydrates in the formula are: maltodextrin, lactose , low substituted hydroxypropyl cellulose and microcrystalline cellulose. Among them, maltodextrin and lactose act as binders in the formula, low-substituted hydroxypropyl cellulose and microcrystalline cellulose act as disintegrating agents, and an appropriate amount of magnesium stearate is added as the formula Lubricant, finally pressed in addition to forming the clamworm special medical purpose formula food tablet.
为了解决上述技术问题,本发明提供的技术方案为一种用于肿瘤患者的海洋生物型特殊医学用途配方食品,按重量百分比,由以下营养成分组成:蛋白质20~30%,脂肪5~10%,碳水化合物70~75%,胆碱0.090~0.100%,肌醇15~20%,牛磺酸0.035~0.06%,余量为质量比为1:20~30的复合维生素和矿物质元素;所述20-60%蛋白质的来源于沙蚕粉。优选的,60%蛋白质的来源于沙蚕粉。In order to solve the above technical problems, the technical solution provided by the present invention is a marine biological special medical formula food for tumor patients, which is composed of the following nutritional ingredients in percentage by weight: protein 20-30%, fat 5-10% , 70-75% carbohydrates, 0.090-0.100% choline, 15-20% inositol, 0.035-0.06% taurine, and the balance is multivitamins and mineral elements with a mass ratio of 1:20-30; The above-mentioned 20-60% protein is derived from clam worm meal. Preferably, 60% of the protein comes from clam worm meal.
其中,所述沙蚕粉是由下述方法制备得到:Wherein, the clam worm powder is prepared by the following method:
(A)用水冲洗过的沙蚕用柠檬酸水溶液清洗;(A) clam worms washed with water are cleaned with aqueous citric acid solution;
(B)将沙蚕置于10%食盐水溶液2小时;(B) placing the clamworm in 10% saline solution for 2 hours;
(C)清除腔肠内容物的沙蚕再移入水溶液清洗;(C) remove the lugworm of the coelenterate content and then move into the aqueous solution for cleaning;
(D)脱盐后的沙蚕在60℃,时间为30min进行加热干燥;(D) The clam worm after desalination is heated and dried at 60° C. for 30 minutes;
(E)将干燥好的沙蚕粉碎成沙蚕粉。粉碎的方法可以为用采用空气分离式超微粉碎机。(E) Crushing the dried clamworm into clamworm powder. The pulverization method can be to use air separation type superfine pulverizer.
其中,所述蛋白质包括沙蚕蛋白、乳清蛋白、精氨酸、L-谷氨酰胺、L-亮氨酸形式提供;脂肪以沙蚕脂肪、二十二碳六烯酸、二十碳五烯酸、α-亚麻酸、n-6亚油酸形式提供;沙蚕糖、碳水化合物以沙蚕、乳糖、麦芽糊精、微晶纤维素、低取代羟丙基纤维素形式提供。Wherein, the protein is provided in the form of clamworm protein, whey protein, arginine, L-glutamine, and L-leucine; the fat is provided in the form of clamworm fat, docosahexaenoic acid, eicosapenta Provided in the form of enoic acid, α-linolenic acid, and n-6 linoleic acid; provided in the form of nereistose, carbohydrates, lactose, maltodextrin, microcrystalline cellulose, and low-substituted hydroxypropyl cellulose.
其中,以占所述配方食品总量的重量百分比,所述蛋白质中包括沙蚕蛋白4.0%~12.5%、乳清蛋白7.2%~10.7%、精氨酸0.42%~2.9%、L-谷氨酰胺0.33%~2.6%、L-亮氨酸0.27%~0.58%。Wherein, the protein includes 4.0% to 12.5% of clamworm protein, 7.2% to 10.7% of whey protein, 0.42% to 2.9% of arginine, 0.42% to 2.9% of arginine, L-glutamine Amide 0.33% to 2.6%, L-leucine 0.27% to 0.58%.
其中,以占所述配方食品总量的重量百分比,所述脂肪中包括沙蚕脂肪0.3%~1.4%、二十二碳六烯酸0.009%~0.02%、二十碳五烯酸2.0%~2.5%、α-亚麻酸0.45%~1.0%、n-6亚油酸3.1%~4.2%。Wherein, in percentage by weight of the total amount of the formula food, the fat includes 0.3% to 1.4% of nereis fat, 0.009% to 0.02% of docosahexaenoic acid, and 2.0% to 2.0% of eicosapentaenoic acid. 2.5%, α-linolenic acid 0.45% to 1.0%, n-6 linoleic acid 3.1% to 4.2%.
其中,以占所述配方食品总量的重量百分比,所述碳水化合物中包括沙蚕糖0.009%~6.5%、乳糖10.7%%~17.2%、麦芽糊精4.2%~14.3%、微晶纤维素30.3%~32.5%、香菇多糖0.0%~14.0%、低取代羟丙基纤维素6.17%~6.54%。Wherein, the carbohydrates include 0.009% to 6.5% of nereisose, 10.7% to 17.2% of lactose, 4.2% to 14.3% of maltodextrin, microcrystalline cellulose 30.3%-32.5%, lentinan 0.0%-14.0%, low-substituted hydroxypropyl cellulose 6.17%-6.54%.
其中,以占所述配方食品总量的重量百分比,所述复合维生素包括维生素A0.14~1.0%、维生素B1 0.0035~0.004‰、维生素B2 0.0035~0.004‰、维生素B60.0035~0.004‰、维生素C 0.095~0.0348‰、维生素D 0.0000034~0.0000135‰、维生素E 0.035~0.04‰、维生素K 0.0001847~0.0001966‰、烟酰胺0.0088mg~0.01‰、叶酸0.00093~0.0012‰、泛酸0.0123~0.04‰和生物素0.0000880~0.0001‰。Wherein, in percentage by weight of the total amount of the formula food, the multivitamins include 0.14-1.0% of vitamin A, 0.0035-0.004‰ of vitamin B1, 0.0035-0.004‰ of vitamin B2, 0.0035-0.004‰ of vitamin B6, 0.0035-0.004‰ of vitamin C 0.095~0.0348‰, vitamin D 0.0000034~0.0000135‰, vitamin E 0.035~0.04‰, vitamin K 0.0001847~0.0001966‰, niacinamide 0.0088mg~0.01‰, folic acid 0.00093~0.00120‰0, pantothenic acid 0.08‰0‰0 and biotin 0.0123~0.04‰0 ~0.0001‰.
其中,以占所述配方食品总量的重量百分比,所述矿物质元素包括钠0.35~0.8%、钾0.47~1.0%、镁0.03g~0.2%、钼0.00022~0.0022‰、锌0.0211~0.15‰、锰2.10~0.0286‰、钙0.14~0.9%、铜0.0025mg~0.0267‰、磷0.35~0.8%和氯1.03~2.9%;Wherein, the mineral elements include sodium 0.35-0.8%, potassium 0.47-1.0%, magnesium 0.03g-0.2%, molybdenum 0.00022-0.0022‰, zinc 0.0211-0.15‰ , manganese 2.10~0.0286‰, calcium 0.14~0.9%, copper 0.0025mg~0.0267‰, phosphorus 0.35~0.8% and chlorine 1.03~2.9%;
其中,所述的钠主要以氯化钠的形式存在;所选化合物的用量需换算成钾元素的含量;Wherein, the sodium mainly exists in the form of sodium chloride; the amount of the selected compound needs to be converted into the content of potassium element;
所述的钾是以氯化钾和磷酸二氢钾的形式存在,所选化合物的用量需换算成钾元素的含量;The potassium exists in the form of potassium chloride and potassium dihydrogen phosphate, and the amount of the selected compound needs to be converted into the content of potassium element;
所述的钙是以碳酸钙和氯化钙的形式存在,所选化合物的用量需换算成钙元素的含量;The calcium exists in the form of calcium carbonate and calcium chloride, and the amount of the selected compound needs to be converted into the content of calcium element;
所述的磷是以磷酸二氢钾的形式存在,所选化合物的用量需换算成磷元素的含量;The phosphorus exists in the form of potassium dihydrogen phosphate, and the amount of the selected compound needs to be converted into the content of phosphorus element;
所述的镁是以氯化镁和硬脂酸镁的形式存在,所选化合物的用量需换算成镁元素的含量;The magnesium exists in the form of magnesium chloride and magnesium stearate, and the amount of the selected compound needs to be converted into the content of magnesium element;
所述的锌是以乳酸锌的形式存在,所选化合物的用量需换算成锌元素的含量;The zinc exists in the form of zinc lactate, and the amount of the selected compound needs to be converted into the content of zinc element;
所述的铜是以五水硫酸铜的形式存在,所选化合物的用量需换算成铜元素的含量;The copper exists in the form of copper sulfate pentahydrate, and the amount of the selected compound needs to be converted into the content of copper element;
所述的锰是以碳酸锰的形式存在;Described manganese exists in the form of manganese carbonate;
所述的氯化物是以氯化钠、氯化钾和氯化钙的形式存在;Described chloride exists in the form of sodium chloride, potassium chloride and calcium chloride;
所述的钼是以二水钼酸钠的形式存在;The molybdenum exists in the form of sodium molybdate dihydrate;
所述的维生素A是β-胡萝卜素。The vitamin A is β-carotene.
其中,所述肿瘤患者特殊医学用途营养配方食品为粉末或颗粒。Wherein, the special medical nutritional formula food for tumor patients is powder or granule.
上述,包括如下步骤:The above, including the following steps:
(1)原料称重,并粉碎;(1) The raw materials are weighed and pulverized;
(2)将沙蚕粉和二十二碳六烯酸、二十碳五烯酸、α-亚麻酸、亚油酸均匀混合,过40目筛,备用;(2) Evenly mix clamworm powder with docosahexaenoic acid, eicosapentaenoic acid, α-linolenic acid, and linoleic acid, pass through a 40-mesh sieve, and set aside;
(3)将乳糖、麦芽糊精、微晶纤维素、香菇多糖、低取代羟丙基纤维素均匀混合,过40目筛,备用;(3) Evenly mix lactose, maltodextrin, microcrystalline cellulose, lentinan, and low-substituted hydroxypropyl cellulose, pass through a 40-mesh sieve, and set aside;
(4)将剩余的维生素类、氨基酸、牛磺酸和无机盐类均匀混合,过40目筛,(4) The remaining vitamins, amino acids, taurine and inorganic salts are evenly mixed, and cross a 40-mesh sieve.
备用;spare;
(5)将上述步骤(2)、(3)和(4)得到的物料均匀混合;(5) uniformly mixing the materials obtained in the above steps (2), (3) and (4);
(6)将步骤(5)得到的物料检验合格后直接装罐,或者进行压片,最后辐照杀菌保藏。(6) The materials obtained in step (5) are inspected and qualified, and then directly filled into cans, or compressed into tablets, and finally irradiated and sterilized for preservation.
与现有技术相比,本发明具有如下有益效果:Compared with the prior art, the present invention has the following beneficial effects:
1)本品包含人体所需要的五大营养素,同时富含胆碱、肌醇、牛磺酸,营养更均衡。1) This product contains the five major nutrients needed by the human body, and is rich in choline, inositol, and taurine, making the nutrition more balanced.
2)L-谷氨酰胺、精氨酸和L-亮氨酸作为特殊营养物质添加到该种特殊医学用途配方食品中,通过给予具有调控免疫作用的营养物质,以达到改善机体营养状况、增强机体免疫功能的作用。2) L-glutamine, arginine and L-leucine are added as special nutrients to this kind of formula food for special medical purposes. By giving nutrients that can regulate immunity, the nutritional status of the body can be improved and the body can be enhanced. The role of the body's immune function.
3)添加ω-3脂肪酸(为必需脂肪酸),其中的二十二碳六烯酸(DHA)和二十碳五烯酸(EPA)可以抑制肿瘤的发生、生长的转移速度;同时可以降低治炎因子的活性、改善人的先天性免疫能力,并使低密度脂蛋白的体内氧化活性增强,在防止炎症和自身免疫方面有一定作用。3) Add omega-3 fatty acids (essential fatty acids), in which docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) can inhibit tumor occurrence, growth and metastasis speed; The activity of inflammatory factors can improve human innate immunity and enhance the oxidation activity of low-density lipoprotein in vivo, which plays a certain role in preventing inflammation and autoimmunity.
4)开创性地使用沙蚕作为蛋白质、脂肪、碳水化合物的来源之一。作为一种优质蛋白质来源,沙蚕蛋白在适用于肿瘤患者的海洋生物型特殊医学用途配方食品中的应用,不仅拓宽了海洋资源的利用率,为今后沙蚕或其他海洋生物来源的添加物应用在特殊人群用肠内营养特殊食品提供宝贵的参考价值。4) Pioneering the use of clam worms as one of the sources of protein, fat, and carbohydrates. As a high-quality protein source, the application of clam worm protein in marine biological special medical formula food suitable for tumor patients not only broadens the utilization rate of marine resources, but also provides a new source of additives for clam worm or other marine organisms in the future. The use of special food for enteral nutrition in special populations provides valuable reference value.
5)严格按照肿瘤病人营养和代谢需求进行组成成分及配比调节,将三大营养素优化到最佳比例,针对性强,效果更佳。5) Strictly adjust the composition and ratio according to the nutritional and metabolic needs of tumor patients, and optimize the three major nutrients to the best ratio, which is more targeted and more effective.
6)上述适用于肿瘤患者的海洋生物型特殊医学用途配方食品,将海洋生物型食材作为全营养配方的来源之一,各组分间协同增效,合理补充全面的营养和充足的能量,能够改善肝癌前病变小鼠的营养代谢状况,抑制肝脏受损,减轻炎症反应,改善治疗效果,提高机体免疫力,且双齿围沙蚕蛋白占制剂总蛋白60%时,营养功效最显著,弥补了国内海洋型生物EN制剂的空白。具有非常重要的社会价值,其制备方法简单,适合规模化工业生产的应用。6) The above-mentioned marine biological special medical formula food suitable for cancer patients uses marine biological food ingredients as one of the sources of complete nutritional formula, synergizes among the components, reasonably supplements comprehensive nutrition and sufficient energy, and can Improve the nutritional metabolism of mice with precancerous lesions of the liver, inhibit liver damage, reduce inflammatory reactions, improve therapeutic effects, and enhance body immunity, and when the protein of C. It filled the blank of domestic marine biological EN preparations. It has very important social value, its preparation method is simple, and it is suitable for the application of large-scale industrial production.
附图说明Description of drawings
图1各组小鼠注射前后1月的体重变化(g);图A代表实施例1,B代表实施例2,C代表实施例3,D代表阳性对照组,E空白组,F对照组。The body weight change (g) in January before and after the injection of each group of mice in Fig. 1; Figure A represents embodiment 1, B represents embodiment 2, C represents embodiment 3, D represents positive control group, E blank group, F control group.
图2各组肝癌前病变小鼠肝组织形态学切片图,黑色圆圈区域指示为明显炎性浸润。Figure 2 Morphological slices of liver tissue in mice with precancerous liver lesions in each group, the black circle area indicates obvious inflammatory infiltration.
具体实施方式Detailed ways
以下部分是具体实施方式对本发明做进一步说明,但以下实施方式仅仅是对本发明的进一步解释,不代表本发明保护范围仅限于此,凡是以本发明的思路所做的等效替换,均在本发明的保护范围。The following part is a specific implementation to further explain the present invention, but the following implementation is only a further explanation of the present invention, and does not mean that the protection scope of the present invention is limited to this, and all equivalent replacements based on the ideas of the present invention are included in this document. protection scope of the invention.
实施例1Example 1
本实施例涉及用于肿瘤患者的海洋生物型特殊医学用途配方食品,具体配方见下表1;其中,蛋白质中含沙蚕蛋白12.36g、乳清蛋白7.21g、精氨酸0.44g、L-谷氨酰胺0.32g和L-亮氨酸0.26g,脂肪中含沙蚕脂肪1.24g、α-亚麻酸0.53g和亚油酸3.15g、二十二碳六烯酸(DHA)0.009g和二十碳五烯酸(EPA)2.29g,碳水化合物中含沙蚕多糖1.80g、低取代羟丙基纤维素6.21g、乳糖15.14g、麦芽糊精13.20g和微晶纤维素30.81g。This example relates to marine biological special medical formula food for cancer patients, the specific formula is shown in Table 1 below; wherein, the protein contains 12.36g of nereis protein, 7.21g of whey protein, 0.44g of arginine, L- Glutamine 0.32g and L-leucine 0.26g, fat contains nereis fat 1.24g, α-linolenic acid 0.53g and linoleic acid 3.15g, docosahexaenoic acid (DHA) 0.009g and di Eicosapentaenoic acid (EPA) 2.29g, carbohydrates include 1.80g claripolysaccharide, 6.21g low-substituted hydroxypropyl cellulose, 15.14g lactose, 13.20g maltodextrin and 30.81g microcrystalline cellulose.
制备时,将固体原料:沙蚕粉、精氨酸、L-谷氨酰胺、L-亮氨酸、乳清蛋白、α-亚麻酸、二十二碳六烯酸(DHA)、二十碳五烯酸(EPA)、亚油酸、低取代羟丙基纤维素、乳糖、麦芽糊精、微晶纤维素、复合矿物质、复合维生素按比例称取,在干混机中混合1小时后过筛,至粒径约为0.8mm。在无菌条件下进行灌装。During preparation, solid raw materials: clam worm powder, arginine, L-glutamine, L-leucine, whey protein, α-linolenic acid, docosahexaenoic acid (DHA), eicosa Pentaenoic acid (EPA), linoleic acid, low-substituted hydroxypropyl cellulose, lactose, maltodextrin, microcrystalline cellulose, complex minerals, and multivitamins are weighed in proportion, and mixed in a dry mixer for 1 hour Sieve until the particle size is about 0.8mm. Filling is performed under aseptic conditions.
表1Table 1
实施例2Example 2
本实施例涉及用于肿瘤患者的海洋生物型特殊医学用途配方食品,具体配方见下表1;其中,蛋白质中含沙蚕蛋白8.24g、乳清蛋白7.25g、精氨酸2.11g、L-谷氨酰胺2.46g和L-亮氨酸0.53g,脂肪中含沙蚕脂肪0.83g、α-亚麻酸0.53g和亚油酸3.57g、二十二碳六烯酸(DHA)0.018g和二十碳五烯酸(EPA)2.27g,碳水化合物中含沙蚕多糖1.2g、低取代羟丙基纤维素6.21g、乳糖15.40g、麦芽糊精13.54g和微晶纤维素30.81g。This example relates to marine biological special medical formula food for cancer patients. The specific formula is shown in Table 1 below; wherein, the protein contains 8.24g of nereis protein, 7.25g of whey protein, 2.11g of arginine, L- Glutamine 2.46g and L-leucine 0.53g, fat contains nereis fat 0.83g, α-linolenic acid 0.53g and linoleic acid 3.57g, docosahexaenoic acid (DHA) 0.018g and di Eicosapentaenoic acid (EPA) 2.27g, carbohydrates containing clam polysaccharide 1.2g, low-substituted hydroxypropyl cellulose 6.21g, lactose 15.40g, maltodextrin 13.54g and microcrystalline cellulose 30.81g.
制备时,将固体原料:沙蚕粉、精氨酸、L-谷氨酰胺、L-亮氨酸、乳清蛋白、α-亚麻酸、二十二碳六烯酸(DHA)、二十碳五烯酸(EPA)、亚油酸、低取代羟丙基纤维素、乳糖、麦芽糊精、微晶纤维素、复合矿物质、复合维生素按比例称取,在干混机中混合1小时后过筛,至粒径约为0.8mm。在无菌条件下进行灌装。During preparation, the solid raw materials: clam worm powder, arginine, L-glutamine, L-leucine, whey protein, α-linolenic acid, docosahexaenoic acid (DHA), eicosa Pentaenoic acid (EPA), linoleic acid, low-substituted hydroxypropyl cellulose, lactose, maltodextrin, microcrystalline cellulose, complex minerals, and multivitamins are weighed in proportion, and mixed in a dry mixer for 1 hour Sieve until the particle size is about 0.8mm. Filling is performed under aseptic conditions.
表2Table 2
实施例3Example 3
本实施例涉及用于肿瘤患者的海洋生物型特殊医学用途配方食品,具体配方见下表1;其中,蛋白质中含沙蚕蛋白4.12g、乳清蛋白10.12g、精氨酸2.73g、L-谷氨酰胺3.08g和L-亮氨酸0.55g,脂肪中含沙蚕脂肪0.41g、α-亚麻酸0.53g和亚油酸3.99g、二十二碳六烯酸(DHA)0.026g和二十碳五烯酸(EPA)2.26g,碳水化合物中含沙蚕多糖0.60g、低取代羟丙基纤维素6.22g、乳糖16.29g、麦芽糊精13.26g和微晶纤维素30.81g。This example relates to marine biological special medical formula food for cancer patients. The specific formula is shown in Table 1 below; wherein, the protein contains 4.12g of clamworm protein, 10.12g of whey protein, 2.73g of arginine, L- Glutamine 3.08g and L-leucine 0.55g, fat contains nereis fat 0.41g, α-linolenic acid 0.53g and linoleic acid 3.99g, docosahexaenoic acid (DHA) 0.026g and di Eicosapentaenoic acid (EPA) 2.26g, carbohydrates containing clam polysaccharide 0.60g, low-substituted hydroxypropyl cellulose 6.22g, lactose 16.29g, maltodextrin 13.26g and microcrystalline cellulose 30.81g.
制备时,将固体原料:沙蚕粉、精氨酸、L-谷氨酰胺、L-亮氨酸、乳清蛋白、α-亚麻酸、二十二碳六烯酸(DHA)、二十碳五烯酸(EPA)、亚油酸、低取代羟丙基纤维素、乳糖、麦芽糊精、微晶纤维素、复合矿物质、复合维生素按比例称取,在干混机中混合1小时后过筛,至粒径约为0.8mm。在无菌条件下进行灌装。During preparation, the solid raw materials: clam worm powder, arginine, L-glutamine, L-leucine, whey protein, α-linolenic acid, docosahexaenoic acid (DHA), eicosa Pentaenoic acid (EPA), linoleic acid, low-substituted hydroxypropyl cellulose, lactose, maltodextrin, microcrystalline cellulose, complex minerals, and multivitamins are weighed in proportion, and mixed in a dry mixer for 1 hour Sieve until the particle size is about 0.8mm. Filling is performed under aseptic conditions.
表3table 3
上述各组分通过特定配比组合,相互协同增效,合理补充全面的营养和充足的能量,减轻肝癌前病变患者应厌食、营养缺乏、体重下降而引起的营养代谢症状。具体体现在如下测试实验中:The above-mentioned components are combined in a specific ratio to synergize with each other, reasonably supplement comprehensive nutrition and sufficient energy, and relieve the symptoms of nutritional metabolism caused by anorexia, nutritional deficiency, and weight loss in patients with precancerous liver lesions. Specifically reflected in the following test experiments:
取本发明实施例1-3所得配方食品进行试验,分别设置为沙蚕处理组1(A60%双齿围沙蚕蛋白/总蛋白w/w)、沙蚕处理组2(B 40%双齿围沙蚕蛋白/总蛋白w/w)、沙蚕处理组3(C 20%双齿围沙蚕蛋白/总蛋白w/w)同时设阳性对照组(D谷氨酰胺+精氨酸蛋白质来源特殊医学用途配方食品组)、空白组(E)和对照组(F),分组如表4。The formula food obtained in Examples 1-3 of the present invention was tested, and they were respectively set as Nereis worm treatment group 1 (A 60% bidentate pericymbin protein/total protein w/w), nereis treatment group 2 (B 40% bidentate Nereis protein/total protein w/w) and Nereis worm treatment group 3 (C 20% bidentate nereis protein/total protein w/w) were simultaneously set up as a positive control group (D glutamine + arginine protein source Formula food group for special medical purposes), blank group (E) and control group (F), the groups are shown in Table 4.
表4:各组处理情况表Table 4: Table of Treatment of Each Group
注:a双齿围沙蚕EN制剂的重量为每片1.0g;b立适康EN制剂的重量为每片1.1g。Note: a The weight of Neris bidenta EN preparation is 1.0 g per tablet; b The weight of Lishikang EN preparation is 1.1 g per tablet.
用1%DEN溶液对A、B、C、D和E组小鼠行腹腔注射0.1ml/10g,1/w,连续注射4w,建立早期肝癌前病变小鼠肿瘤模型。The mice in groups A, B, C, D, and E were intraperitoneally injected with 1% DEN solution at 0.1ml/10g, 1/w, for 4w consecutively, to establish mouse tumor models with early liver precancerous lesions.
自首次注射12h起,A组、B组和C组按1320.06kJ/kg/d给予不同取代度的双齿围沙蚕肠内营养制剂(2片/只/d),D组给予相同热量的谷氨酰胺+精氨酸蛋白质来源特殊医学用途配方食品组(2片/只/d)。E组和F组给予相同热量的饲料。12 hours from the first injection, groups A, B, and C were given enteral nutrition preparations (2 tablets/piece/d) with different degrees of substitution at 1320.06 kJ/kg/d, and group D was given the same caloric Glutamine + arginine protein source formula food group for special medical purposes (2 tablets/piece/d). Group E and Group F were given the same caloric feed.
从注射和喂养第一天起每周称量小鼠体重两次,第四周末,禁食12h小时,取肝脏,制成组织病理切片,光学显微镜下(10×40倍)观察肝脏组织形态学变化。从而评价所述海洋生物型配方食品作为肿瘤患者特殊医学用途营养配方食品的有效性和可行性。Weigh the mice twice a week from the first day of injection and feeding, fast for 12 hours at the end of the fourth week, take the liver, make histopathological sections, and observe the morphology of the liver tissue under an optical microscope (10×40 times) Variety. Therefore, the effectiveness and feasibility of the marine biotype formula food as nutritional formula food for special medical purposes of tumor patients were evaluated.
实验结果如图1和图2所示,可以看出实施例1-3所述的肿瘤患者特殊医学用途营养配方食品能够补充早期肝癌前病变患者的营养提高小鼠的体重。组织切片图结果显示沙蚕组小鼠肝脏肝细胞变性和核异型性减轻,巨噬细胞浸润减少。The experimental results are shown in Figures 1 and 2. It can be seen that the nutritional formula food for special medical use for tumor patients described in Examples 1-3 can supplement the nutrition of patients with early liver precancerous lesions and increase the weight of mice. The results of histological sections showed that the degeneration and nuclear atypia of liver cells in the clam worm group were alleviated, and the infiltration of macrophages was reduced.
综合以上所有的实验结果,总体而言我们可以看到沙蚕特殊医学用途配方食品组与谷氨酰胺+精氨酸蛋白质来源特殊医学用途配方食品组相比有更好的营养支持效果,且双齿围沙蚕蛋白占制剂总蛋白60%时,营养功效最显著。所以,我们有理由证明,沙蚕特殊医学用途配方食品对于肝癌前病变患者营养的营养支持是有作用的。Based on all the above experimental results, we can generally see that the clam worm formula food for special medical purpose group has a better nutritional support effect than the glutamine + arginine protein source formula food for special medical purpose group, and both When the clam worm protein accounts for 60% of the total protein of the preparation, the nutritional effect is the most significant. Therefore, we have reason to prove that clamworm special medical purpose formula food is effective in nutritional support for patients with precancerous liver lesions.
本实验沙蚕蛋白、沙蚕多糖、沙蚕脂肪是以沙蚕粉的形式添加进去的,并没有独立提取和购买。In this experiment, nereist protein, nereist polysaccharide, and nereist fat were added in the form of nereist powder, and were not extracted and purchased independently.
Claims (10)
- A kind of 1. marine organism type special medicine purposes formula food for tumor patient, which is characterized in that percentage by weight Than being made of following nutritional ingredient:Protein 20~30%, fat 5~10%, carbohydrate 70~75%, choline 0.090 ~0.100%, inositol 15~20%, taurine 0.035~0.06%, surplus is that mass ratio is 1:20~30 multi-vitamins And mineral matter element;The 20-60% protein derives from clam worm powder.
- 2. formula food according to claim 1, which is characterized in that the clam worm powder is prepared by following methods:(A) clam worm being rinsed with water is cleaned with aqueous citric acid solution;(B) clam worm is placed in 10% common salt aqueous solution 2 hours;(C) clam worm for removing coelenteron content moves into aqueous cleaning again;(D) at 60 DEG C, the time is thermally dried the clam worm after desalination for 30min;(E) dried clam worm is ground into clam worm powder.
- 3. formula food according to claim 1, which is characterized in that the protein include clam worm albumen, lactalbumin, Arginine, L-Glutamine, L-Leu form provide;Fat is with clam worm fat, docosahexaenoic acid, eicosapentaenoic Acid, alpha-linolenic acid, n-6 linoleic acid form provide;Clam worm sugar, carbohydrate are with clam worm, lactose, maltodextrin, microcrystalline cellulose Element, low-substituted hydroxypropyl cellulose form provide.
- 4. formula food according to claim 1, which is characterized in that account for the weight percent of the formula food total amount Than, the protein include clam worm albumen 4.0%~12.5%, lactalbumin 7.2%~10.7%, arginine 0.42%~ 2.9%th, L-Glutamine 0.33%~2.6%, L-Leu 0.27%~0.58%.
- 5. formula food according to claim 1, which is characterized in that account for the weight percent of the formula food total amount Than the fat includes clam worm fat 0.3%~1.4%, docosahexaenoic acid 0.009%~0.02%, 20 light dydrocarbons Olefin(e) acid 2.0%~2.5%, alpha-linolenic acid 0.45%~1.0%, n-6 linoleic acid 3.1%~4.2%.
- 6. formula food according to claim 3, which is characterized in that account for the weight percent of the formula food total amount Than the carbohydrate includes clam worm sugar 0.009%~6.5%, lactose 10.7%~17.2%, maltodextrin 4.2% ~14.3%, microcrystalline cellulose 30.3%~32.5%, lentinan 0.0%~14.0%, low-substituted hydroxypropyl cellulose 6.17%~6.54%.
- 7. formula food according to claim 1, which is characterized in that account for the weight percent of the formula food total amount Than the multi-vitamins include vitamin A 0.14~1.0%, vitamin B1 0.0035~0.004 ‰, vitamin B2 0.0035~0.004 ‰, vitamin B6 0.0035~0.004 ‰, vitamin C 0.095~0.0348 ‰, vitamin D 0.0000034~0.0000135 ‰, vitamin E 0.035~0.04 ‰, vitamin K 0.0001847~0.0001966 ‰, Niacinamide 0.0088mg~0.01 ‰, folic acid 0.00093~0.0012 ‰, pantothenic acid 0.0123~0.04 ‰ and biotin 0.0000880~0.0001 ‰.
- 8. formula food according to claim 1, which is characterized in that account for the weight percent of the formula food total amount Than, the mineral matter element include sodium 0.35~0.8%, potassium 0.47~1.0%, magnesium 0.03g~0.2%, molybdenum 0.00022~ 0.0022 ‰, zinc 0.0211~0.15 ‰, manganese 2.10~0.0286 ‰, calcium 0.14~0.9%, copper 0.0025mg~ 0.0267 ‰, phosphorus 0.35~0.8% and chlorine 1.03~2.9%.
- 9. formula food according to claim 8, it is characterised in that:The sodium mainly exists in the form of sodium chloride, The used in amounts of selected compounds is converted into the content of sodium element;The potassium is existed in the form of potassium chloride and potassium dihydrogen phosphate, and the used in amounts of selected compounds is converted into potassium element Content;The calcium is existed in the form of calcium carbonate and calcium chloride, and the used in amounts of selected compounds is converted into containing for calcium constituent Amount;The phosphorus is existed in the form of potassium dihydrogen phosphate, and the used in amounts of selected compounds is converted into the content of P elements;The magnesium is existed in the form of magnesium chloride and magnesium stearate, and the used in amounts of selected compounds is converted into containing for magnesium elements Amount;The zinc is existed in the form of zinc lactate, and the used in amounts of selected compounds is converted into the content of Zn-ef ficiency;The copper is existed in the form of cupric sulfate pentahydrate, and the used in amounts of selected compounds is converted into the content of copper;The manganese is existed in the form of manganese carbonate;The chloride is existed in the form of sodium chloride, potassium chloride and calcium chloride;The molybdenum is existed in the form of Sodium Molybdate Dihydrate;The vitamin A is beta carotene.
- 10. the preparation method of formula food according to claim 9, which is characterized in that include the following steps:(1) raw material is weighed, and is crushed;(2) clam worm powder and docosahexaenoic acid, eicosapentaenoic acid, alpha-linolenic acid, linoleic acid are uniformly mixed, crosses 40 mesh Sieve, it is spare;(3) lactose, maltodextrin, microcrystalline cellulose, lentinan, low-substituted hydroxypropyl cellulose are uniformly mixed, crosses 40 mesh Sieve, it is spare;(4) remaining vitamins, amino acid, taurine and inorganic salts are uniformly mixed, cross 40 mesh sieve,It is spare;(5) material that above-mentioned steps (2), (3) and (4) obtain uniformly is mixed;(6) material for obtaining step (5) direct tinning or progress tabletting after the assay was approved, last radiation sterilizing preservation.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810073989.7A CN108142936A (en) | 2018-01-25 | 2018-01-25 | A kind of marine organism type special medicine purposes formula food for tumor patient |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810073989.7A CN108142936A (en) | 2018-01-25 | 2018-01-25 | A kind of marine organism type special medicine purposes formula food for tumor patient |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108142936A true CN108142936A (en) | 2018-06-12 |
Family
ID=62456837
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810073989.7A Pending CN108142936A (en) | 2018-01-25 | 2018-01-25 | A kind of marine organism type special medicine purposes formula food for tumor patient |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108142936A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109717475A (en) * | 2019-01-28 | 2019-05-07 | 山东省科学院生物研究所 | A kind of special medicine purposes formula food containing marine organisms rouge |
CN110916195A (en) * | 2019-11-25 | 2020-03-27 | 中国海洋大学 | Total nutrient tumor formula food added with specific marine oligopeptide and preparation method thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105852092A (en) * | 2016-04-12 | 2016-08-17 | 上海海洋大学 | Nutritional formula food for tumor patients and for special medical purposes, and production method thereof |
CN105901703A (en) * | 2016-04-19 | 2016-08-31 | 上海海洋大学 | A marine organism type enteral nutrition preparation used for burn patients |
CN107149102A (en) * | 2017-05-22 | 2017-09-12 | 福建海唯美海洋生物科技有限公司 | The health-preserving food formula and manufacturing process of a kind of marine organisms |
-
2018
- 2018-01-25 CN CN201810073989.7A patent/CN108142936A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105852092A (en) * | 2016-04-12 | 2016-08-17 | 上海海洋大学 | Nutritional formula food for tumor patients and for special medical purposes, and production method thereof |
CN105901703A (en) * | 2016-04-19 | 2016-08-31 | 上海海洋大学 | A marine organism type enteral nutrition preparation used for burn patients |
CN107149102A (en) * | 2017-05-22 | 2017-09-12 | 福建海唯美海洋生物科技有限公司 | The health-preserving food formula and manufacturing process of a kind of marine organisms |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109717475A (en) * | 2019-01-28 | 2019-05-07 | 山东省科学院生物研究所 | A kind of special medicine purposes formula food containing marine organisms rouge |
CN110916195A (en) * | 2019-11-25 | 2020-03-27 | 中国海洋大学 | Total nutrient tumor formula food added with specific marine oligopeptide and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102238947B (en) | Nutrient composition | |
CN106962912A (en) | A kind of hepatopathy tailored version clinical nutrition formula and preparation method thereof | |
CN107242550A (en) | A kind of male sterility tailored version clinical nutrition formula and preparation method thereof | |
CN106983136A (en) | A kind of puerperium conditioning tailored version clinical nutrition formula and preparation method thereof | |
CN101703248B (en) | Enteral nutritional preparation containing marine bioactivity polysaccharide as well as preparation method and application thereof | |
CN112089051A (en) | Nutritional composition for improving body inflammatory signs of tumor patients and preparation method thereof | |
CN107319525A (en) | One kind fat-reducing fat reducing tailored version clinical nutrition formula and preparation method thereof | |
CN104839718A (en) | Powder-form full-nutrient formula food and production process thereof | |
CN107319524A (en) | A kind of nephrosis tailored version clinical nutrition formula and preparation method thereof | |
CN110301629A (en) | A kind of full nutrient solid beverage of tumor patient and preparation method thereof | |
CN103431392B (en) | Composite marine food for special dietary uses for diabetics | |
CN105852092A (en) | Nutritional formula food for tumor patients and for special medical purposes, and production method thereof | |
CN101569410A (en) | Special meal nutritional foods used by tumor patients | |
CN108703364A (en) | Treating fatty acid metabolism tailored version clinical nutrition formula and preparation method thereof | |
CN108703365A (en) | Protein allergy tailored version clinical nutrition formula and preparation method thereof | |
CN105768108A (en) | Special dietary food suitable for taking of tumor patients | |
CN102613453B (en) | Marine organism type enteral nutrition preparation for diabetes patients, preparation method of marine organism type enteral nutrition preparation and application | |
CN107440102A (en) | A kind of climacteric women tailored version clinical nutrition formula and preparation method thereof | |
KR100874859B1 (en) | Manufacturing method of health food pill with melon seed as main ingredient | |
JP2008280322A (en) | Bone strength improving agent | |
CN102429149A (en) | A kind of enteral nutrition preparation containing salted egg white protein polypeptide and preparation method thereof | |
CN109329902A (en) | A kind of leukemia of children tailored version clinical nutrition formula and preparation method thereof | |
CN103404765B (en) | Composite marine special dietary food for consumption of tumor patients | |
CN108142936A (en) | A kind of marine organism type special medicine purposes formula food for tumor patient | |
CN107616507A (en) | A kind of ocean polypeptide spy's dietary seafood for chornic arthritis edible for patients |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180612 |
|
RJ01 | Rejection of invention patent application after publication |